Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

This company has been moved to the archive! The financial data has not been updated since February 14, 2022.

Analysis of Profitability Ratios 

Microsoft Excel LibreOffice Calc

Profitability Ratios (Summary)

Edwards Lifesciences Corp., profitability ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Return on Sales
Gross profit margin 76.13% 75.36% 74.37% 74.77% 74.52%
Operating profit margin 32.30% 20.46% 26.38% 20.10% 31.89%
Net profit margin 28.73% 18.77% 24.08% 19.40% 16.99%
Return on Investment
Return on equity (ROE) 25.76% 18.00% 25.24% 23.00% 19.74%
Return on assets (ROA) 17.68% 11.38% 16.14% 13.57% 10.25%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Edwards Lifesciences Corp. gross profit margin ratio improved from 2019 to 2020 and from 2020 to 2021.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Edwards Lifesciences Corp. operating profit margin ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Edwards Lifesciences Corp. net profit margin ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Edwards Lifesciences Corp. ROE deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.
ROA A profitability ratio calculated as net income divided by total assets. Edwards Lifesciences Corp. ROA deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Gross Profit Margin

Edwards Lifesciences Corp., gross profit margin calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in thousands)
Gross profit 3,983,600  3,305,700  3,233,600  2,783,400  2,560,000 
Net sales 5,232,500  4,386,300  4,348,000  3,722,800  3,435,300 
Profitability Ratio
Gross profit margin1 76.13% 75.36% 74.37% 74.77% 74.52%
Benchmarks
Gross Profit Margin, Competitors2
Abbott Laboratories 52.21% 50.49% 52.46% 51.32% 47.75%
Bristol-Myers Squibb Co. 78.57% 72.31% 69.10% 70.98% 70.80%
CVS Health Corp. 17.48% 18.01% 17.41% 15.92% 15.45%
Danaher Corp. 60.95% 55.98% 55.74% 55.83% 55.61%
Elevance Health Inc. 17.09% 19.71% 18.77% 21.29% 18.89%
Intuitive Surgical Inc. 69.32% 65.65% 69.45% 69.92% 70.12%
Medtronic PLC 65.19% 67.41% 70.04% 69.77% 68.73%
UnitedHealth Group Inc. 23.60% 25.62% 23.19% 23.33% 22.98%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Gross profit margin = 100 × Gross profit ÷ Net sales
= 100 × 3,983,600 ÷ 5,232,500 = 76.13%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Edwards Lifesciences Corp. gross profit margin ratio improved from 2019 to 2020 and from 2020 to 2021.

Operating Profit Margin

Edwards Lifesciences Corp., operating profit margin calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in thousands)
Operating income 1,690,300  897,600  1,146,800  748,200  1,095,500 
Net sales 5,232,500  4,386,300  4,348,000  3,722,800  3,435,300 
Profitability Ratio
Operating profit margin1 32.30% 20.46% 26.38% 20.10% 31.89%
Benchmarks
Operating Profit Margin, Competitors2
Abbott Laboratories 19.56% 15.48% 14.21% 11.94% 6.30%
Bristol-Myers Squibb Co. 15.91% -21.60% 22.62% 22.69% 17.39%
CVS Health Corp. 4.54% 5.19% 4.69% 2.07% 5.15%
Danaher Corp. 25.35% 18.99% 18.25% 17.11% 16.48%
Elevance Health Inc. 5.15% 4.97% 5.49% 5.55% 4.50%
Intuitive Surgical Inc. 31.89% 24.09% 30.69% 32.21% 33.71%
Medtronic PLC 14.89% 16.57% 20.51% 22.20% 17.94%
UnitedHealth Group Inc. 8.40% 8.76% 8.19% 7.71% 7.60%
Operating Profit Margin, Sector
Health Care Equipment & Services 8.50% 6.25% 8.26% 7.53% 7.58%
Operating Profit Margin, Industry
Health Care 15.63% 11.30% 13.81% 13.27% 14.16%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Operating profit margin = 100 × Operating income ÷ Net sales
= 100 × 1,690,300 ÷ 5,232,500 = 32.30%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Edwards Lifesciences Corp. operating profit margin ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Net Profit Margin

Edwards Lifesciences Corp., net profit margin calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in thousands)
Net income 1,503,100  823,400  1,046,900  722,200  583,600 
Net sales 5,232,500  4,386,300  4,348,000  3,722,800  3,435,300 
Profitability Ratio
Net profit margin1 28.73% 18.77% 24.08% 19.40% 16.99%
Benchmarks
Net Profit Margin, Competitors2
Abbott Laboratories 16.42% 12.99% 11.56% 7.74% 1.74%
Bristol-Myers Squibb Co. 15.08% -21.20% 13.15% 21.81% 4.85%
CVS Health Corp. 2.72% 2.68% 2.59% -0.31% 3.58%
Danaher Corp. 21.84% 16.36% 16.80% 13.33% 13.60%
Elevance Health Inc. 4.46% 3.78% 4.66% 4.11% 4.31%
Intuitive Surgical Inc. 29.85% 24.33% 30.80% 30.29% 21.09%
Medtronic PLC 11.97% 16.56% 15.16% 10.36% 13.56%
UnitedHealth Group Inc. 6.06% 6.03% 5.76% 5.33% 5.28%
Net Profit Margin, Sector
Health Care Equipment & Services 6.58% 4.13% 5.83% 4.75% 5.18%
Net Profit Margin, Industry
Health Care 13.09% 8.19% 11.46% 9.68% 8.05%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Net profit margin = 100 × Net income ÷ Net sales
= 100 × 1,503,100 ÷ 5,232,500 = 28.73%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Edwards Lifesciences Corp. net profit margin ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Return on Equity (ROE)

Edwards Lifesciences Corp., ROE calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in thousands)
Net income 1,503,100  823,400  1,046,900  722,200  583,600 
Stockholders’ equity 5,835,900  4,574,300  4,148,300  3,140,400  2,956,200 
Profitability Ratio
ROE1 25.76% 18.00% 25.24% 23.00% 19.74%
Benchmarks
ROE, Competitors2
Abbott Laboratories 19.75% 13.71% 11.86% 7.76% 1.54%
Bristol-Myers Squibb Co. 19.46% -23.84% 6.66% 35.07% 8.58%
CVS Health Corp. 10.54% 10.35% 10.39% -1.02% 17.57%
Danaher Corp. 14.24% 9.17% 9.94% 9.40% 9.45%
Elevance Health Inc. 16.93% 13.77% 15.15% 13.14% 14.50%
Intuitive Surgical Inc. 14.32% 10.90% 16.69% 16.89% 13.97%
Medtronic PLC 7.01% 9.44% 9.25% 6.12% 8.01%
UnitedHealth Group Inc. 24.09% 23.52% 24.02% 23.19% 22.10%
ROE, Sector
Health Care Equipment & Services 15.73% 9.48% 12.76% 10.91% 12.58%
ROE, Industry
Health Care 25.10% 15.53% 21.67% 18.26% 14.09%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
ROE = 100 × Net income ÷ Stockholders’ equity
= 100 × 1,503,100 ÷ 5,835,900 = 25.76%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Edwards Lifesciences Corp. ROE deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Return on Assets (ROA)

Edwards Lifesciences Corp., ROA calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in thousands)
Net income 1,503,100  823,400  1,046,900  722,200  583,600 
Total assets 8,502,600  7,237,100  6,488,100  5,323,700  5,695,800 
Profitability Ratio
ROA1 17.68% 11.38% 16.14% 13.57% 10.25%
Benchmarks
ROA, Competitors2
Abbott Laboratories 9.40% 6.20% 5.43% 3.53% 0.63%
Bristol-Myers Squibb Co. 6.40% -7.61% 2.65% 14.06% 3.00%
CVS Health Corp. 3.39% 3.11% 2.98% -0.30% 6.96%
Danaher Corp. 7.73% 4.79% 4.85% 5.54% 5.34%
Elevance Health Inc. 6.26% 5.28% 6.21% 5.24% 5.45%
Intuitive Surgical Inc. 12.58% 9.50% 14.17% 14.37% 11.46%
Medtronic PLC 3.87% 5.28% 5.16% 3.40% 4.04%
UnitedHealth Group Inc. 8.15% 7.81% 7.96% 7.87% 7.59%
ROA, Sector
Health Care Equipment & Services 6.23% 3.64% 4.97% 4.38% 5.24%
ROA, Industry
Health Care 9.17% 5.26% 7.49% 6.56% 5.31%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
ROA = 100 × Net income ÷ Total assets
= 100 × 1,503,100 ÷ 8,502,600 = 17.68%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. Edwards Lifesciences Corp. ROA deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.